APA (7th ed.) Citation

Perez, E. A., de Haas, S. L., Eiermann, W., Barrios, C. H., Toi, M., Im, Y., . . . Burris, H. A. 3. (2019). Correction to: Relationship between tumor biomarkers and efficacy in MARIANNE, a phase III study of trastuzumab emtansine ± pertuzumab versus trastuzumab plus taxane in HER2-positive advanced breast cancer. BMC Cancer, 19(1), N.PAG. https://doi.org/10.1186/s12885-019-5831-x

Chicago Style (17th ed.) Citation

Perez, Edith A., et al. "Correction to: Relationship Between Tumor Biomarkers and Efficacy in MARIANNE, a Phase III Study of Trastuzumab Emtansine ± Pertuzumab Versus Trastuzumab Plus Taxane in HER2-positive Advanced Breast Cancer." BMC Cancer 19, no. 1 (2019): N.PAG. https://doi.org/10.1186/s12885-019-5831-x.

MLA (9th ed.) Citation

Perez, Edith A., et al. "Correction to: Relationship Between Tumor Biomarkers and Efficacy in MARIANNE, a Phase III Study of Trastuzumab Emtansine ± Pertuzumab Versus Trastuzumab Plus Taxane in HER2-positive Advanced Breast Cancer." BMC Cancer, vol. 19, no. 1, 2019, p. N.PAG, https://doi.org/10.1186/s12885-019-5831-x.